William Blair initiated coverage of Sotera Health (SHC) with an Outperform rating and no price target The firm says the company’s financial profile offers “sticky customer relationships, significant recurring revenue, meaningful pricing power, and best-in-class margins.” Sotera has competitive advantages in each of its three business units due to its integrated offerings and high switching costs, the analyst tells investors in a research note.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SHC:
- Sotera Health: Integrated Market Leadership, Easing Litigation Overhang, and Valuation Upside Support Buy Rating
- Sotera Health 16.2M share Block Trade priced at $16.50
- BMO Capital’s Buy Rating on Sotera Health: Positive Outlook Amid Growth Resurgence and Strategic Strengths
- Sotera Health initiated with an Outperform at BMO Capital
- Sotera Health Stockholders Sell 30 Million Shares